Avert-IT

Medical techniques for avoiding Adverse Events currently exist, but clinicians don#t have a reliable way to predict the occurrence, so there is no opportunity for intervention.

Research indicates average lengths of stay can be reduced by up to 30%, and outcomes improved for a similar proportion of patients, if these Adverse Events can be avoided through prediction and intervention. Potential savings across the EU exceed 5 billion euros, annually.

A model for predicting Adverse Events offers potential for improving outcomes across a wide range of conditions and or illnesses.

The main objectives of the project are:

• Understanding the association between multiple patient parameters and arterial hypotension (sudden drop in blood pressure)
• Development of a software application to predict the occurrence of arterial hypotension based on recognition of the associations described above
• Validation of the solution in clinical trials
• Exploitation model for the commercialisation of the software in product/service sales across international markets

For further information, please visit:
http://avertit.wordpress.com (Avert-IT Project Blog)

Project co-ordinator:
Pera Innovation Ltd.

Partners:

• C3 Amulet Ltd
• Uppsala Universitet
• Universitätsklinikum Heidelberg
• Azienda Ospedaleria San Gerardo Di Monza
• Kauno Technologijos Universitetas
• The University Of Glasgow
• Greater Glasgow Health Board
• Hospital Universitari Vall d'Hebron
• Philips Medizin Systeme Böblingen Gmbh.

Timetable: from 01/2008 € to 12/2010

Total cost: € 2.286.138

EC funding: € 1.780.000

Programme Acronym: FP7-ICT

Subprogramme Area: Advanced ICT for risk assessment and patient safety

Contract type: Collaborative project (generic)

• New FP7 eHealth Project - Avert-IT